FDA Inspection
WES Pharma Inc.WES Pharma Inc. – FDA Inspection, Apr 19, 2019
Record Details
This FDA Inspection record concerns WES Pharma Inc., with an inspection on April 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 77a565d3-899b-466f-9b49-b46e7e538afb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1088267
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of WES Pharma Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2025 | VAI | Baltimore District Office | Drug Quality Assurance |
| November 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for WES Pharma Inc.
- FDA Inspection 1290200 - 2025-11-20
- FDA Inspection 1223324 - 2023-11-21
- FDA Inspection 1162565 - 2022-02-18
- FDA Inspection 1141774 - 2021-04-28
- FDA Inspection 1114327 - 2019-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.